scholarly article | Q13442814 |
P50 | author | John D. Hayes | Q38318853 |
Michael McMahon | Q39606285 | ||
P2093 | author name string | Masayuki Yamamoto | |
Ken Itoh | |||
Nerys Thomas | |||
P2860 | cites work | Crystal structure of the BTB domain from PLZF | Q22003945 |
Structure of the Cul1-Rbx1-Skp1-F boxSkp2 SCF ubiquitin ligase complex | Q24294734 | ||
Structure of a beta-TrCP1-Skp1-beta-catenin complex: destruction motif binding and lysine specificity of the SCF(beta-TrCP1) ubiquitin ligase | Q24306203 | ||
Specific patterns of electrophile adduction trigger Keap1 ubiquitination and Nrf2 activation | Q40403963 | ||
RhoBTB2 is a substrate of the mammalian Cul3 ubiquitin ligase complex | Q40563288 | ||
BTB proteins are substrate-specific adaptors in an SCF-like modular ubiquitin ligase containing CUL-3. | Q40633677 | ||
Increased protein stability as a mechanism that enhances Nrf2-mediated transcriptional activation of the antioxidant response element. Degradation of Nrf2 by the 26 S proteasome | Q40688004 | ||
F-box/WD-repeat proteins pop1p and Sud1p/Pop2p form complexes that bind and direct the proteolysis of cdc18p | Q41646870 | ||
Identification of a novel Nrf2-regulated antioxidant response element (ARE) in the mouse NAD(P)H:quinone oxidoreductase 1 gene: reassessment of the ARE consensus sequence | Q42157111 | ||
Degradation of transcription factor Nrf2 via the ubiquitin-proteasome pathway and stabilization by cadmium | Q44222495 | ||
Keap1 regulates both cytoplasmic-nuclear shuttling and degradation of Nrf2 in response to electrophiles | Q44373729 | ||
Keap1, the sensor for electrophiles and oxidants that regulates the phase 2 response, is a zinc metalloprotein. | Q46467626 | ||
Identification of sensor cysteines in human Keap1 modified by the cancer chemopreventive agent sulforaphane | Q46854767 | ||
The BTB protein MEL-26 is a substrate-specific adaptor of the CUL-3 ubiquitin-ligase. | Q47069071 | ||
Targeting of protein ubiquitination by BTB–Cullin 3–Roc1 ubiquitin ligases | Q50337002 | ||
The double-edged sword of Nrf2: subversion of redox homeostasis during the evolution of cancer | Q53348313 | ||
VHL-box and SOCS-box domains determine binding specificity for Cul2-Rbx1 and Cul5-Rbx2 modules of ubiquitin ligases | Q24322407 | ||
Stable X chromosome inactivation involves the PRC1 Polycomb complex and requires histone MACROH2A1 and the CULLIN3/SPOP ubiquitin E3 ligase | Q24529056 | ||
BTB protein Keap1 targets antioxidant transcription factor Nrf2 for ubiquitination by the Cullin 3-Roc1 ligase | Q24558689 | ||
Keap1 is a redox-regulated substrate adaptor protein for a Cul3-dependent ubiquitin ligase complex | Q24559743 | ||
Oxidative stress sensor Keap1 functions as an adaptor for Cul3-based E3 ligase to regulate proteasomal degradation of Nrf2 | Q24563807 | ||
Mechanism of SMRT corepressor recruitment by the BCL6 BTB domain | Q27642845 | ||
Mechanisms underlying ubiquitination | Q27860656 | ||
Function and regulation of cullin-RING ubiquitin ligases | Q28131707 | ||
The kelch repeat superfamily of proteins: propellers of cell function | Q28140778 | ||
Homodimer of two F-box proteins betaTrCP1 or betaTrCP2 binds to IkappaBalpha for signal-dependent ubiquitination | Q28143145 | ||
The Keap1 BTB/POZ dimerization function is required to sequester Nrf2 in cytoplasm | Q28216217 | ||
Redox-regulated turnover of Nrf2 is determined by at least two separate protein domains, the redox-sensitive Neh2 degron and the redox-insensitive Neh6 degron | Q28261724 | ||
The SCF ubiquitin ligase: insights into a molecular machine | Q28279993 | ||
Crystal structure of the Kelch domain of human Keap1 | Q28287182 | ||
Keap1 recruits Neh2 through binding to ETGE and DLG motifs: characterization of the two-site molecular recognition model | Q28910182 | ||
Transcription factor Nrf2 coordinately regulates a group of oxidative stress-inducible genes in macrophages | Q29614557 | ||
Keap1-dependent proteasomal degradation of transcription factor Nrf2 contributes to the negative regulation of antioxidant response element-driven gene expression | Q29615644 | ||
Structural basis for defects of Keap1 activity provoked by its point mutations in lung cancer | Q29616499 | ||
The Keap1-BTB protein is an adaptor that bridges Nrf2 to a Cul3-based E3 ligase: oxidative stress sensing by a Cul3-Keap1 ligase | Q29616502 | ||
Protection against electrophile and oxidant stress by induction of the phase 2 response: fate of cysteines of the Keap1 sensor modified by inducers | Q29616503 | ||
Distinct Cysteine Residues in Keap1 Are Required for Keap1-Dependent Ubiquitination of Nrf2 and for Stabilization of Nrf2 by Chemopreventive Agents and Oxidative Stress | Q29617845 | ||
A hitchhiker's guide to the cullin ubiquitin ligases: SCF and its kin | Q29618006 | ||
Keap1-null mutation leads to postnatal lethality due to constitutive Nrf2 activation | Q29618051 | ||
Beta-TrCP recognizes a previously undescribed nonphosphorylated destruction motif in Cdc25A and Cdc25B phosphatases | Q33756957 | ||
Modifying specific cysteines of the electrophile-sensing human Keap1 protein is insufficient to disrupt binding to the Nrf2 domain Neh2 | Q33900511 | ||
In-depth mutational analysis of the promyelocytic leukemia zinc finger BTB/POZ domain reveals motifs and residues required for biological and transcriptional functions | Q33965235 | ||
Regulation of the Caenorhabditis elegans oxidative stress defense protein SKN-1 by glycogen synthase kinase-3. | Q34132410 | ||
The many faces of beta-TrCP E3 ubiquitin ligases: reflections in the magic mirror of cancer | Q35691542 | ||
Cullin-based ubiquitin ligases: Cul3-BTB complexes join the family. | Q35740993 | ||
The BACK domain in BTB-kelch proteins. | Q35950674 | ||
Evolutionary conserved N-terminal domain of Nrf2 is essential for the Keap1-mediated degradation of the protein by proteasome | Q35974394 | ||
Identification of the interactive interface and phylogenic conservation of the Nrf2-Keap1 system. | Q38363758 | ||
P433 | issue | 34 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | ubiquitination | Q33059483 |
P304 | page(s) | 24756-24768 | |
P577 | publication date | 2006-06-21 | |
P1433 | published in | Journal of Biological Chemistry | Q867727 |
P1476 | title | Dimerization of substrate adaptors can facilitate cullin-mediated ubiquitylation of proteins by a "tethering" mechanism: a two-site interaction model for the Nrf2-Keap1 complex | |
P478 | volume | 281 |
Q55461978 | 2-Deoxy-D-glucose and 6-aminonicotinamide-mediated Nrf2 down regulation leads to radiosensitization of malignant cells via abrogation of GSH-mediated defense |
Q90451937 | A Naturally-Occurring Dominant-Negative Inhibitor of Keap1 Competitively against Its Negative Regulation of Nrf2 |
Q58701423 | A catalogue of somatic NRF2 gain-of-function mutations in cancer |
Q39710585 | A noncanonical mechanism of Nrf2 activation by autophagy deficiency: direct interaction between Keap1 and p62. |
Q37336872 | ALS-FTLD associated mutations of SQSTM1 impact on Keap1-Nrf2 signalling |
Q38742679 | Absolute Amounts and Status of the Nrf2-Keap1-Cul3 Complex within Cells |
Q28579883 | Actinfilin is a Cul3 substrate adaptor, linking GluR6 kainate receptor subunits to the ubiquitin-proteasome pathway |
Q33707203 | Activation of NRF2 by nitrosative agents and H2O2 involves KEAP1 disulfide formation |
Q38298598 | Activation of Nrf2-regulated glutathione pathway genes by ischemic preconditioning |
Q55392669 | Activation of p62/SQSTM1-Keap1-Nuclear Factor Erythroid 2-Related Factor 2 Pathway in Cancer. |
Q41592607 | Activation of the Nrf2/ARE signaling pathway by probucol contributes to inhibiting inflammation and neuronal apoptosis after spinal cord injury |
Q24336527 | Adaptor protein self-assembly drives the control of a cullin-RING ubiquitin ligase |
Q38207006 | Aging, immunosenescence and membrane rafts: the lipid connection |
Q35200121 | Altered behavioral development in Nrf2 knockout mice following early postnatal exposure to valproic acid. |
Q36994823 | Analysis of dimerization of BTB-IVR domains of Keap1 and its interaction with Cul3, by molecular modeling |
Q26800229 | Antioxidant responses and cellular adjustments to oxidative stress |
Q28386384 | Arsenic‐Mediated Activation of the Nrf2‐Keap1 Antioxidant Pathway |
Q28391506 | Basic principles and emerging concepts in the redox control of transcription factors |
Q28277430 | Bood POZ containing gene type 2 is a human counterpart of yeast Btb3p and promotes the degradation of terminal deoxynucleotidyltransferase |
Q28384997 | CACUL1/CAC1 Regulates the Antioxidant Response by Stabilizing Nrf2 |
Q33967276 | CR6-interacting factor 1 (CRIF1) regulates NF-E2-related factor 2 (NRF2) protein stability by proteasome-mediated degradation |
Q37071189 | Cell signaling pathways involved in drug-mediated fetal hemoglobin induction: Strategies to treat sickle cell disease |
Q37217435 | Cellular stress response: a novel target for chemoprevention and nutritional neuroprotection in aging, neurodegenerative disorders and longevity. |
Q28384232 | Cellular stress responses, the hormesis paradigm, and vitagenes: novel targets for therapeutic intervention in neurodegenerative disorders |
Q37359358 | Characterization of RhoBTB-dependent Cul3 ubiquitin ligase complexes--evidence for an autoregulatory mechanism |
Q36851342 | Characterization of the cancer chemopreventive NRF2-dependent gene battery in human keratinocytes: demonstration that the KEAP1-NRF2 pathway, and not the BACH1-NRF2 pathway, controls cytoprotection against electrophiles as well as redox-cycling comp |
Q36539849 | Chemical and biological mechanisms of phytochemical activation of Nrf2 and importance in disease prevention |
Q34222619 | Chemistry of the cysteine sensors in Kelch-like ECH-associated protein 1 |
Q92950658 | Conformational Dynamics of the HIV-Vif Protein Complex |
Q38558127 | Conservation of the Keap1-Nrf2 System: An Evolutionary Journey through Stressful Space and Time. |
Q100311434 | Control of craniofacial and brain development by Cullin3-RING ubiquitin ligases: Lessons from human disease genetics |
Q45921478 | Cross-talk between transcription factors AhR and Nrf2: lessons for cancer chemoprevention from dioxin. |
Q37398830 | Cul3-mediated Nrf2 ubiquitination and antioxidant response element (ARE) activation are dependent on the partial molar volume at position 151 of Keap1. |
Q21203558 | Cullin-RING ubiquitin ligases: global regulation and activation cycles |
Q28118714 | Cullin3-KLHL15 ubiquitin ligase mediates CtIP protein turnover to fine-tune DNA-end resection |
Q24629359 | Cysteine-based regulation of the CUL3 adaptor protein Keap1 |
Q37811619 | Cytochrome P450-mediated pulmonary metabolism of carcinogens: regulation and cross-talk in lung carcinogenesis |
Q54380424 | Development of an efficient E. coli expression and purification system for a catalytically active, human Cullin3-RINGBox1 protein complex and elucidation of its quaternary structure with Keap1. |
Q28306504 | Dietary Diacetylene Falcarindiol Induces Phase 2 Drug-Metabolizing Enzymes and Blocks Carbon Tetrachloride-Induced Hepatotoxicity in Mice through Suppression of Lipid Peroxidation |
Q28075814 | Dietary Phytochemicals in Neuroimmunoaging: A New Therapeutic Possibility for Humans? |
Q27647812 | Different Electrostatic Potentials Define ETGE and DLG Motifs as Hinge and Latch in Oxidative Stress Response |
Q24646029 | Direct interaction between Nrf2 and p21(Cip1/WAF1) upregulates the Nrf2-mediated antioxidant response |
Q28085561 | Discovery of direct inhibitors of Keap1-Nrf2 protein-protein interaction as potential therapeutic and preventive agents |
Q28821830 | Dual NRF2 paralogs in Coho salmon and their antioxidant response element targets |
Q50069776 | Dual Roles of Oxidative Stress in Metal Carcinogenesis |
Q37119963 | Dual roles of Nrf2 in cancer |
Q53821856 | Effects of mulberry leaves on production performance and the potential modulation of antioxidative status in laying hens |
Q38869922 | Emerging role of NRF2 in chemoresistance by regulating drug-metabolizing enzymes and efflux transporters. |
Q28396785 | Emerging roles of Nrf2 and phase II antioxidant enzymes in neuroprotection |
Q39472400 | Enhanced sensitivity of A549 cells to the cytotoxic action of anticancer drugs via suppression of Nrf2 by procyanidins from Cinnamomi Cortex extract |
Q36211986 | Epigallocatechin-3-Gallate Reduces Cytotoxic Effects Caused by Dental Monomers: A Hypothesis. |
Q90478608 | Fibroblast Growth Factor 1 Ameliorates Diabetes-Induced Liver Injury by Reducing Cellular Stress and Restoring Autophagy |
Q64292797 | Fruit-Derived Polyphenol Supplementation for Athlete Recovery and Performance |
Q90212257 | Genome-Wide CRISPR Screen Reveals Autophagy Disruption as the Convergence Mechanism That Regulates the NRF2 Transcription Factor |
Q38664878 | Glycosylation of KEAP1 links nutrient sensing to redox stress signaling. |
Q42702448 | Grape seed proanthocyanidins ameliorates cadmium-induced renal injury and oxidative stress in experimental rats through the up-regulation of nuclear related factor 2 and antioxidant responsive elements |
Q28545231 | HDAC inhibitors increase NRF2-signaling in tumour cells and blunt the efficacy of co-adminstered cytotoxic agents |
Q30414556 | Heat shock proteins in neurodegenerative disorders and aging |
Q37912075 | Hormetics: Dietary Triggers of an Adaptive Stress Response |
Q28385517 | Hrd1 suppresses Nrf2-mediated cellular protection during liver cirrhosis |
Q34632786 | Human aldo-keto reductases: Function, gene regulation, and single nucleotide polymorphisms |
Q47106243 | Hydralazine induces stress resistance and extends C. elegans lifespan by activating the NRF2/SKN-1 signalling pathway. |
Q35905381 | Hypertension-causing Mutations in Cullin3 Protein Impair RhoA Protein Ubiquitination and Augment the Association with Substrate Adaptors. |
Q36288735 | Identification of retinoic acid as an inhibitor of transcription factor Nrf2 through activation of retinoic acid receptor alpha |
Q37120398 | In Vitro and in Vivo Characterization of a Tunable Dual-Reactivity Probe of the Nrf2-ARE Pathway |
Q92689773 | JNK Phosphorylates The Neh6 Domain Of Nrf2 And Downregulates Cytoprotective Genes In Acetaminophen-Induced Liver Injury |
Q49834826 | KEAP1 and Done? Targeting the NRF2 Pathway with Sulforaphane |
Q91896751 | KLF2 Protects against Osteoarthritis by Repressing Oxidative Response through Activation of Nrf2/ARE Signaling In Vitro and In Vivo |
Q39579939 | KPNA6 (Importin α7)-Mediated Nuclear Import of Keap1 Represses the Nrf2-Dependent Antioxidant Response |
Q39523928 | Keap1 Mutations and Nrf2 Pathway Activation in Epithelial Ovarian Cancer |
Q33734064 | Keap1 is a forked-stem dimer structure with two large spheres enclosing the intervening, double glycine repeat, and C-terminal domains |
Q30497261 | Keap1 perceives stress via three sensors for the endogenous signaling molecules nitric oxide, zinc, and alkenals |
Q38920601 | Keap1, the cysteine-based mammalian intracellular sensor for electrophiles and oxidants. |
Q57753359 | Keap1-MCM3 interaction is a potential coordinator of molecular machineries of antioxidant response and genomic DNA replication in metazoa |
Q38022427 | Keap1: One stone kills three birds Nrf2, IKKβ and Bcl-2/Bcl-xL |
Q47279133 | Kelch-like ECH-associated protein 1 (KEAP1) differentially regulates nuclear factor erythroid-2-related factors 1 and 2 (NRF1 and NRF2). |
Q35555898 | Kinetic analyses of Keap1-Nrf2 interaction and determination of the minimal Nrf2 peptide sequence required for Keap1 binding using surface plasmon resonance |
Q27681060 | Kinetic, Thermodynamic, and Structural Characterizations of the Association between Nrf2-DLGex Degron and Keap1 |
Q38955183 | MDA-7/IL-24 inhibits Nrf2-mediated antioxidant response through activation of p38 pathway and inhibition of ERK pathway involved in cancer cell apoptosis |
Q28817936 | Macrophage Migration Inhibitory Factor as an Emerging Drug Target to Regulate Antioxidant Response Element System |
Q34387857 | Mechanism of Cullin3 E3 Ubiquitin Ligase Dimerization |
Q28482975 | Mechanism of chemical activation of Nrf2 |
Q33763536 | Mechanisms and functions of Nrf2 signaling in Drosophila |
Q28394732 | Mechanisms of activation of the transcription factor Nrf2 by redox stressors, nutrient cues, and energy status and the pathways through which it attenuates degenerative disease |
Q37865512 | Mechanisms of induction of cytosolic and microsomal glutathione transferase (GST) genes by xenobiotics and pro-inflammatory agents |
Q39405227 | Metabolic switching and cell fate decisions: implications for pluripotency, reprogramming and development |
Q53290445 | Molecular cross-talk between the NRF2/KEAP1 signaling pathway, autophagy, and apoptosis |
Q46787391 | Molecular effects of cancer-associated somatic mutations on the structural and target recognition properties of Keap1. |
Q44138968 | Molecular evolution of Keap1. Two Keap1 molecules with distinctive intervening region structures are conserved among fish |
Q26778356 | Molecular mechanisms of Nrf2 regulation and how these influence chemical modulation for disease intervention |
Q37073173 | Molecular mechanisms of Nrf2-mediated antioxidant response |
Q38200391 | Monitoring Keap1-Nrf2 interactions in single live cells |
Q36782739 | Multiple Weak Linear Motifs Enhance Recruitment and Processivity in SPOP-Mediated Substrate Ubiquitination |
Q40709652 | Multiple binding modes of a small molecule to human Keap1 revealed by X-ray crystallography and molecular dynamics simulation. |
Q90244978 | NF-κB and Keap1 Interaction Represses Nrf2-Mediated Antioxidant Response in Rabbit Hemorrhagic Disease Virus Infection |
Q106513210 | NFE2L2 binds KEAP1:NEDD8-CUL3:RBX1 |
Q36671866 | NRF2 Orchestrates the Metabolic Shift during Induced Pluripotent Stem Cell Reprogramming. |
Q88582817 | NRF2 and the Hallmarks of Cancer |
Q55287213 | NRF2 regulates the glutamine transporter Slc38a3 (SNAT3) in kidney in response to metabolic acidosis. |
Q50020783 | Negative regulation of the Keap1-Nrf2 pathway by a p62/Sqstm1 splicing variant. |
Q28254462 | Negative regulation of the Nrf1 transcription factor by its N-terminal domain is independent of Keap1: Nrf1, but not Nrf2, is targeted to the endoplasmic reticulum |
Q41980350 | New strategies to inhibit KEAP1 and the Cul3-based E3 ubiquitin ligases. |
Q36277241 | Non-electrophilic modulators of the canonical Keap1/Nrf2 pathway |
Q90410805 | Nordihydroguaiaretic Acid: From Herbal Medicine to Clinical Development for Cancer and Chronic Diseases |
Q47350229 | Nrf2 at the Heart of Oxidative Stress and Cardiac Protection |
Q36467640 | Nrf2 is controlled by two distinct β-TrCP recognition motifs in its Neh6 domain, one of which can be modulated by GSK-3 activity. |
Q34993085 | Nrf2 is overexpressed in pancreatic cancer: implications for cell proliferation and therapy |
Q39830008 | Nrf2 promotes neuronal cell differentiation |
Q45423906 | Nrf2, a guardian of healthspan and gatekeeper of species longevity |
Q37785105 | Nrf2-ARE stress response mechanism: A control point in oxidative stress-mediated dysfunctions and chronic inflammatory diseases |
Q36327991 | Nrf2/ARE Pathway Involved in Oxidative Stress Induced by Paraquat in Human Neural Progenitor Cells |
Q35763004 | Nrf2b, novel zebrafish paralog of oxidant-responsive transcription factor NF-E2-related factor 2 (NRF2). |
Q28383171 | Nuclear Factor-Erythroid-2-Related Factor 2 in Aging and Lung Fibrosis |
Q37643674 | Orchestrating redox signaling networks through regulatory cysteine switches |
Q37571787 | Oregano Essential Oil Induces SOD1 and GSH Expression through Nrf2 Activation and Alleviates Hydrogen Peroxide-Induced Oxidative Damage in IPEC-J2 Cells. |
Q26799344 | Overview of Nrf2 as Therapeutic Target in Epilepsy |
Q37166218 | Overview on how oncogenic Kras promotes pancreatic carcinogenesis by inducing low intracellular ROS levels |
Q35955120 | Oxidative Stress and Mitochondrial Dysfunction in Down’s Syndrome: Relevance to Aging and Dementia |
Q38702248 | Oxidative stress and chronic inflammation in osteoarthritis: can NRF2 counteract these partners in crime? |
Q36420949 | Oxidative stress, mammospheres and Nrf2-new implication for breast cancer therapy? |
Q35867950 | PALB2 interacts with KEAP1 to promote NRF2 nuclear accumulation and function |
Q28384526 | PGAM5 tethers a ternary complex containing Keap1 and Nrf2 to mitochondria |
Q44554497 | Peptide inhibitors of the Keap1-Nrf2 protein-protein interaction with improved binding and cellular activity |
Q36051913 | Pharmacokinetics and pharmacodynamics of orally administered acetylenic tricyclic bis(cyanoenone), a highly potent Nrf2 activator with a reversible covalent mode of action. |
Q24655442 | Physiological significance of reactive cysteine residues of Keap1 in determining Nrf2 activity |
Q89920945 | Potential Applications of NRF2 Modulators in Cancer Therapy |
Q39064638 | Preventive and protective roles of dietary Nrf2 activators against central nervous system diseases |
Q38067805 | Principles in Redox Signaling: From Chemistry to Functional Significance |
Q36144939 | Probing the structural requirements of non-electrophilic naphthalene-based Nrf2 activators. |
Q30371642 | Prospective type 1 and type 2 disulfides of Keap1 protein. |
Q88655489 | Protective Potential of the Glutathione Peroxidase-1 Gene in Abnormal Behaviors Induced by Phencyclidine in Mice |
Q36745578 | Proteomic analysis of ubiquitin ligase KEAP1 reveals associated proteins that inhibit NRF2 ubiquitination |
Q38711149 | RETRACTED: Nuclear factor erythroid 2-related factor 2 enhances carcinogenesis by suppressing apoptosis and promoting autophagy in nickel-transformed cells |
Q58571567 | Redox Homeostasis and Natural Dietary Compounds: Focusing on Antioxidants of Rice ( L.) |
Q37924028 | Redox-regulating role of insulin: The essence of insulin effect |
Q27324641 | Regulation of Drosophila Metamorphosis by Xenobiotic Response Regulators |
Q92476511 | Regulation of position effect variegation at pericentric heterochromatin by Drosophila Keap1-Nrf2 xenobiotic response factors |
Q34252986 | Regulation of the Nrf2-Keap1 antioxidant response by the ubiquitin proteasome system: an insight into cullin-ring ubiquitin ligases |
Q37191843 | Regulatory flexibility in the Nrf2-mediated stress response is conferred by conformational cycling of the Keap1-Nrf2 protein complex |
Q39606140 | SCF/{beta}-TrCP promotes glycogen synthase kinase 3-dependent degradation of the Nrf2 transcription factor in a Keap1-independent manner. |
Q34680962 | S[+] Apomorphine is a CNS penetrating activator of the Nrf2-ARE pathway with activity in mouse and patient fibroblast models of amyotrophic lateral sclerosis |
Q90179743 | Seaweed natural products modify the host inflammatory response via Nrf2 signaling and alter colon microbiota composition and gene expression |
Q35333484 | Sex hormonal regulation and hormesis in aging and longevity: role of vitagenes |
Q28386244 | Small Molecule Modulators of Keap1‐Nrf2‐ARE Pathway as Potential Preventive and Therapeutic Agents |
Q53659826 | Somatic mutations of the KEAP1 gene in common solid cancers |
Q64259267 | Sorting out the Value of Cruciferous Sprouts as Sources of Bioactive Compounds for Nutrition and Health |
Q92378590 | Spermidine Confers Liver Protection by Enhancing NRF2 Signaling Through a MAP1S-Mediated Noncanonical Mechanism |
Q28384783 | Stress-activated cap'n'collar transcription factors in aging and human disease |
Q47903962 | Stress-sensing mechanisms and the physiological roles of the Keap1-Nrf2 system during cellular stress |
Q27675990 | Structural Basis for Cul3 Protein Assembly with the BTB-Kelch Family of E3 Ubiquitin Ligases |
Q36172880 | Structural and functional characterization of Nrf2 degradation by the glycogen synthase kinase 3/β-TrCP axis |
Q38522152 | Structural basis of Keap1 interactions with Nrf2. |
Q46976303 | Subcellular localization and cytoplasmic complex status of endogenous Keap1. |
Q55060241 | Sulforaphane Protects against Brain Diseases: Roles of Cytoprotective Enzymes. |
Q37792074 | Superoxide anion and hydrogen peroxide-induced signaling and damage in angiotensin II and aldosterone action |
Q91013930 | Targeted protein degradation: expanding the toolbox |
Q90678050 | Targeting Cancer Stem Cell Redox Metabolism to Enhance Therapy Responses |
Q34376139 | Targeting nrf2 signaling to combat chemoresistance |
Q27341433 | The C-terminal domain of Nrf1 negatively regulates the full-length CNC-bZIP factor and its shorter isoform LCR-F1/Nrf1β; both are also inhibited by the small dominant-negative Nrf1γ/δ isoforms that down-regulate ARE-battery gene expression |
Q34769739 | The Cullin-RING E3 ubiquitin ligase CRL4-DCAF1 complex dimerizes via a short helical region in DCAF1. |
Q38837451 | The Keap1-Nrf2-ARE Pathway As a Potential Preventive and Therapeutic Target: An Update |
Q89529709 | The NRF2 Signaling Network Defines Clinical Biomarkers and Therapeutic Opportunity in Friedreich's Ataxia |
Q37802176 | The Nrf2 system as a potential target for the development of indirect antioxidants. |
Q26822972 | The Nrf2-ARE Pathway: A Valuable Therapeutic Target for the Treatment of Neurodegenerative Diseases |
Q34984506 | The Nrf2-ARE cytoprotective pathway in astrocytes |
Q64235040 | The Nrf2/HO-1 axis can be a prognostic factor in clear cell renal cell carcinoma |
Q34579435 | The PTEN/NRF2 axis promotes human carcinogenesis |
Q36349182 | The Relevance of Nrf2 Pathway and Autophagy in Pancreatic Cancer Cells upon Stimulation of Reactive Oxygen Species. |
Q41825131 | The Role of Glucosinolate Hydrolysis Products from Brassica Vegetable Consumption in Inducing Antioxidant Activity and Reducing Cancer Incidence. |
Q28279051 | The cancer chemopreventive actions of phytochemicals derived from glucosinolates |
Q28389296 | The complexity of the Nrf2 pathway: beyond the antioxidant response |
Q37848718 | The cytoprotective role of the Keap1-Nrf2 pathway |
Q37163747 | The emerging family of CULLIN3-RING ubiquitin ligases (CRL3s): cellular functions and disease implications. |
Q37271797 | The emerging role of the Nrf2-Keap1 signaling pathway in cancer |
Q37689226 | The hypertension drug, verapamil, activates Nrf2 by promoting p62-dependent autophagic Keap1 degradation and prevents acetaminophen-induced cytotoxicity |
Q38889475 | The role of modulation of antioxidant enzyme systems in the treatment of neurodegenerative diseases |
Q39013645 | The role of nuclear factor-erythroid 2 related factor 2 (Nrf-2) in the protection against lung injury |
Q24300456 | The selective autophagy substrate p62 activates the stress responsive transcription factor Nrf2 through inactivation of Keap1 |
Q26778368 | The spatiotemporal regulation of the Keap1-Nrf2 pathway and its importance in cellular bioenergetics |
Q58436305 | The transcription factor Nrf2 as a new therapeutic target in Parkinson's disease |
Q37188181 | The ubiquitin conjugating enzyme, UbcM2, engages in novel interactions with components of cullin-3 based E3 ligases |
Q27921848 | Toxicity testing in the 21st century: a vision and a strategy |
Q37380419 | Vascular NAD(P)H oxidase activation in diabetes: a double-edged sword in redox signalling |
Q34341268 | Visualization of the Drosophila dKeap1-CncC interaction on chromatin illumines cooperative, xenobiotic-specific gene activation. |
Q38945976 | WNT-3A regulates an Axin1/NRF2 complex that regulates antioxidant metabolism in hepatocytes. |
Q64121611 | aPKCι promotes gallbladder cancer tumorigenesis and gemcitabine resistance by competing with Nrf2 for binding to Keap1 |
Q37954688 | p62 at the Interface of Autophagy, Oxidative Stress Signaling, and Cancer |
Q28392820 | p62 links autophagy and Nrf2 signaling |
Q58583990 | p62-Keap1-NRF2-ARE Pathway: A Contentious Player for Selective Targeting of Autophagy, Oxidative Stress and Mitochondrial Dysfunction in Prion Diseases |
Q24310885 | p62/SQSTM1 is a target gene for transcription factor NRF2 and creates a positive feedback loop by inducing antioxidant response element-driven gene transcription |
Search more.